Skip to main content

Carl Zeiss Meditec AG (CZMWF) Stock

Carl Zeiss Meditec AG Stock Details, Movements and Public Alerts

Stock Details

Carl Zeiss Meditec AG (CZMWF), a prominent company in the healthcare sector within the medical instruments & supplies industry, is based in Germany and primarily trades on the PNK.Currently, the stock is trading at $39.96. Over the past 52 weeks, it has ranged between $26.42 and $55.75. This places the current price at 71.7% of its 52-week high and 51.2% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 82.23, suggesting overbought conditions. The stock is currently trading above its 50-day moving average of $35.56 by 12.37%. Similarly, it is above its 200-day moving average of $34.98 by 14.24%. The MACD histogram is 0.15, indicating bullish momentum (MACD Line: 1.45, Signal Line: 1.31). There are currently 5 active alerts set for CZMWF by users.

52-Week Range

$55.75 - $26.42

-28.32% from high · +51.25% from low

Avg Daily Volume

53

20-day average

100-day avg: 91

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

20.60

Near market average

Forward P/E

12.55

Earnings expected to grow

PEG Ratio

1.18

Reasonably valued

Price to Book

1.18

EV/EBITDA

18.43

EPS (TTM)

$1.59

Price to Sales

1.31

Beta

1.35

Similar volatility to market

Q:How is CZMWF valued relative to its earnings and growth?
Carl Zeiss Meditec AG trades at a P/E ratio of 20.60, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 12.55 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.18 indicates reasonable value when growth is considered.
Q:What is CZMWF's risk profile compared to the market?
With a beta of 1.35, Carl Zeiss Meditec AG is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 1.18 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

5.57%

Operating Margin

11.06%

EBITDA

$217.84M

Revenue Growth (YoY)

2.40%

Earnings Growth (YoY)

97.50%

Q:How profitable and efficient is CZMWF's business model?
Carl Zeiss Meditec AG achieves a profit margin of 5.57%, meaning it retains $5.57 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 11.06% reveals how efficiently the company runs its core business operations before interest and taxes.
Q:What are CZMWF's recent growth trends?
Carl Zeiss Meditec AG's revenue grew by 2.40% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 97.50% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against Medical Instruments & Supplies industry averages for proper context.

Dividend Information

Dividend Per Share

$0.63

Dividend Yield

1.58%

Q:What dividend income can investors expect from CZMWF?
Carl Zeiss Meditec AG offers a dividend yield of 1.58%, paying $0.63 per share annually. This modest yield below 2% suggests the company prioritizes growth investments over current income. While the dividend provides some return, investors are likely attracted more by capital appreciation potential than income generation.
Q:How reliable is CZMWF's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - Carl Zeiss Meditec AG pays $0.63 per share in dividends against earnings of $1.59 per share, resulting in a payout ratio of 39.62%. This balanced payout between 30-60% suggests a sustainable dividend policy that allows both shareholder returns and business reinvestment. The dividend appears well-covered by earnings.

Company Size & Market

Market Cap

$2.9B

Revenue (TTM)

$2.18B

Revenue/Share (TTM)

$25.03

Shares Outstanding

87.54M

Book Value/Share

$27.81

Asset Type

EQUITY

Q:What is CZMWF's market capitalization and position?
Carl Zeiss Meditec AG has a market capitalization of $2.9B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 87.54M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Medical Instruments & Supplies industry, it competes with other firms in this sector.
Q:How does CZMWF's price compare to its book value?
Carl Zeiss Meditec AG's book value per share is $27.81, while the current stock price is $39.96, resulting in a price-to-book (P/B) ratio of 1.44. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Sep 15, 2026, 02:23 AM

Technical Indicators

RSI (14-day)

82.23

Overbought

50-Day Moving Average

$35.56

12.37% above MA-50

200-Day Moving Average

$34.98

14.24% above MA-200

MACD Line

1.45

MACD Signal

1.31

MACD Histogram

0.15

Bullish

Q:What does CZMWF's RSI value tell investors?
The RSI (Relative Strength Index) for CZMWF is currently 82.23, indicating the stock is in overbought territory (above 70). This suggests strong recent buying pressure that may be unsustainable. While overbought conditions can persist in strong trends, traders often watch for RSI divergences or a drop below 70 as potential sell signals. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret CZMWF's MACD and moving average crossovers?
MACD analysis shows the MACD line at 1.45 above the signal line at 1.31, with histogram at 0.15. This bullish crossover suggests upward momentum is building. The 50-day MA ($35.56) is above the 200-day MA ($34.98), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Sep 16, 2026, 12:37 AM

Active Alerts

Alert Condition
Price decreases by
Threshold
7%
Created
Sep 8, 2026, 04:10 PM
Alert Condition
Forward P/E falls below
Threshold
11.77 x
Created
Aug 19, 2026, 09:10 AM
Alert Condition
Price decreases by
Threshold
8%
Created
Aug 19, 2026, 09:10 AM
Alert Condition
MA Breakout (Bearish)
Threshold
200 days
Created
Aug 19, 2026, 09:10 AM
Alert Condition
Earnings Announcement
Threshold
3 days
Created
Jan 26, 2026, 05:13 PM

Stay Ahead of the Market with Carl Zeiss Meditec AG Alerts

Set up price alerts for Carl Zeiss Meditec AG and get notified instantly when the price hits your target. Never miss an important price movement again.